BUB3 Inhibitors

The term Bub3 inhibitors does not pertain to a specific chemical class but rather encompasses a broad array of compounds and agents intricately designed to hinder the activity of the Bub3 protein. Bub3 holds a pivotal role as an integral component of the mitotic checkpoint complex, a critical regulator ensuring accurate chromosome separation during cell division. The inhibitors devised to target Bub3 are meticulously engineered to disrupt its participation in this complex regulatory network. The landscape of Bub3 inhibitors spans a spectrum of molecular architectures, encompassing small organic molecules, peptides, siRNA molecules, and engineered agents, each with its distinct properties.

BUB3 inhibitors represent a class of chemicals designed to interfere with the function of BUB3, a crucial component of the spindle assembly checkpoint (SAC) involved in ensuring accurate chromosome segregation during cell division. These inhibitors can directly target BUB3 or indirectly influence its activity through disrupting associated pathways. One notable BUB3 inhibitor is BAY 1217389, which selectively inhibits BUB3 and interferes with its association with BUB1, disrupting proper kinetochore-microtubule attachment and mitotic progression. GSK923295 is another compound that inhibits the interaction between BUB1 and BUB3, impacting the SAC and mitotic progression. TAK-960, a potent Aurora kinase inhibitor, indirectly affects BUB3 by disrupting the spindle assembly checkpoint and preventing proper mitotic progression. Additionally, compounds like S9066 and BAY 1151393 directly target BUB3, potentially interfering with its role in chromosome segregation during mitosis. These BUB3 inhibitors provide valuable tools for studying the intricate regulatory mechanisms of mitotic progression.